The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 27-38

  Bruck, Rafael ^a   Aeed, Hussein ^a   Shirin, Haim ^a   Matas, Zipora ^a   Zaidel, Liliana ^a   Avni, Yona ^a   Halpern, Zamir ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Dimethylsulfoxide; Fulminant hepatitis; N acetylcysteine; Nitric oxide; Thioacetamide; Tumor necrosis factor

Indexed keywords

ACETYLCYSTEINE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; GLUTATHIONE; HYDROXYL RADICAL; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOXIFYLLINE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SULFINIC ACID DERIVATIVE; THIOACETAMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEPATIC ENCEPHALOPATHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FAILURE; LIVER HISTOLOGY; LIVER PROTECTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; SURVIVAL RATE;

EID: 0033035268     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80160-3     Document Type: Article

References (76)

1. O'Grady J, Schalman SW, Williams R. Acute liver failure: redefining the syndrome. Lancet. 324:1993;273-275.
2. Lee WR. Acute liver failure. N Engl J Med. 329:1993;1862-1872.
3. Grimm G, Ferenci P, Katzenshlager R, Madl C, Schneeweiss B, Laggner AN, et al. Improvement of hepatic encephalopathy with flumazenil. Lancet. ii:1988;1392-1394.
4. Mehta JM, Karamarkar SG, Pimparkar BD, Sheth UK. Levodopa in the treatment of hepatic coma due to fulminant hepatic failure. J Postgrad Med. 22:1976;32-36.
5. Sinclair SB, Greig PD, Blendis LM, Abecassis M., Roberts EA, Phillips MJ, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest. 84:1989;1063-1069.
6. Denis J, Opolon P, Delorme ML, Granger A, Darnis F. Longterm extra-corporeal assistance by continuous haemofiltration during fulminant hepatic failure. Gastroenterol Clin Biol. 3:1979;337-348.
7. Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med. 107:1987;337-341.
8. Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. McIntyre N, Benhamou JP, Bircher J, Rizzeto M, Rodes J, . Oxford Textbook of Clinical Hepatology. 1991;942 Oxford University Press, Oxford.
9. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology. 9:1989;595-601.
10. Larsen FS, Knudsen GM, Paulson OB, Vilstrup H. Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. J Hepatol. 21:1994;491-495.
11. Chieli E, Malvaldi G. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology. 31:1984;41-52.
12. Porter WR, Neal RA. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab Dispos. 6:1978;379-388.
13. Hunter AL, Holscher MA, Neal RA. Thioactamide-induced hepatic necrosis. Involvement of the mixed-function oxidase enzyme system. J Pharmacol Exp Ther. 200:1977;439-448.
14. Slater TF. Free radical mechanisms in tissue injury. Biochem J. 222:1984;1-15.
15. Machlin LJ, Bendich A. Free radical tissue damage: protective role of anti oxidant nutrients. FASEB J. 1:1987;441-445.
16. Bacon BR, Tavill AT, Brittenham GM, Park CH, Recknagel RO. Hepatic lipid peroxidationin vivo in rats with chronic iron overload. J Clin Invest. 71:1983;429-439.
17. Kyle ME, Miccadei S, Nakae D, Farber JL. Superoxide dismutase and catalase protect cultured hepatocytes from the cytotoxicity of acetaminophen. Biochem Biophys Res Commun. 149:1987;889-896.
18. Shaw S, Jayatilleke E, Ross WA, Gordon E, Lieber CS. Ethanol induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine. J Lab Clin Med. 98:1981;417-424.
19. s+: activation of NF-κB, selective inhibition of antioxidants and integral membrane localization. EMBO J. 11:1993;2991-2998.
20. 4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology. 22:1995;1474-1481.
21. Brown KE, Poulos JE, Li L, Soweid AM, Ramm GA, O'Neil R, et al. Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. Am J Physiol. 272:1997;G116-G123.
22. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HC, Weech GA, et al. Plasma tumor necrosis factor- predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 14:1990;255-259.
23. Khoruts A, Stahnke L, McClain CL, Logan G, Allen J. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 13:1991;267-276.
24. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 18:1993;576-580.
25. 1 in acute rat liver injury. Growth Factors. 1:1989;219-226.
26. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, et al. Thein vitro andin vivo association of transforming growth factor- with hepatic fibrosis. J Cell Biol. 108:1989;2477-2482.
27. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 9:1989;349-351.
28. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor-α production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology. 10:1989;769-773.
29. Lehman V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine treated mice. J Exp Med. 165:1987;657-663.
30. Hishinuma I, Nagakawa KI, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, et al. Involvement of tumor necrosis factor- in development of hepatic injury in galactosamine sensitized mice. Hepatology. 12:1990;1187-1191.
31. Czaja MJ, Xu J, Alt A. Prevention of carbon tetrachloride-induced liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 108:1995;1849-1854.
32. Czaja MJ, Schilsky ML, Xu Y, Schmiedeberg P, Compton A, Ridnour L, et al. The induction of MnSOD gene expression in a hepatic model of TNF-α toxicity does not result in increased protein. Am J Physiol. 266:1994;G737-G744.
33. Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in ratsin vivo. J Clin Invest. 71:1983;980-991.
34. Bruno MK, Cohen SD, Khairallah EA. Antidotal effectiveness ofN-acetylcysteine in reversing acetaminophen-induced hepatotoxicity. Biochem Pharmacol. 37:1988;4319-4325.
35. Mathieson PW, Williams G, MacSweeney JE. Survival after massive ingestional carbon tetrachloride treated by intravenous infusion of acetylcysteine. Hum Toxicol. 4:1985;627-631.
36. Moncada S, Higgs. The L-argininitric oxide pathway. N Engl J Med. 329:1993;2002-2010.
37. Billiar TR. The delicate balance of nitric oxide and superoxide in liver pathology. Gastroenterology. 108:1995;603-605.
38. Geller D. An rat model of hepatic encephalopathy due to fulminant hepatic failure: the role of supportive therapy. Soeters PB, Wilson JHP, Meijer AJ, Holm E, . Advances in Ammonia Metabolism and Hepatic Encephalopathy. 1988;213-217 Elsevier Science Publishers, Amsterdam.
39. Niehaus WG, Samuelsson JR, Wills ED. Lipid peroxide formation in microsomes. Biochem J. 113:1969;315-341.
40. Babbs CF, Steiner MG. Detection and quantitation of hydroxyl radical using dimethyl sulfoxide as molecular probe. Methods Enzymol. 186:1990;137-147.
41. Mullen KD. Evaluation of the suitability of galactoseamine-induced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and rabbit. Soeters PB, Wilson JHP, Meijer AJ, Holm E, . Advances in Ammonia Metabolism and Hepatic Encephalopathy. 1988;205-211 Elsevier Science Publishers, Amsterdam.
42. Shirin H, Bruck R, Aeed H, Frenkel D, Zaidel L, Kenet G, et al. Pentoxifylline prevents concanavalin A-induced hepatitis by reducing TNF-α levels and inhibiting adhesion of T lymphocytes to extracellular matrix. J Hepatol. 29:1998;60-67.
43. Bruck R, Shirin H, Hershkoviz R, Lider O, Kenet G, Aeed H, et al. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumor necrosis factor as therapeutic modalities for concanavalin A-induced hepatitis in mice. Gut. 40:1997;133-138.
44. Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, et al. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective randomized trial. Blood. 82:1993;732-736.
45. Neuner P, Klosner G, Pornmojib M, Knobler R, Schwarz T. Pentoxifyllinein vivo andin vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology. 90:1997;435-439.
46. Wang P, Ba FZ, Morrison MH, Ayala A, Chaudry IH. Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma, hemorrhage and resuscitation. Surgery. 112:1992;451-458.
47. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GM, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 303:1991;1026-1029.
48. Harrison PM, Wendon JA, Gimson AE, Alexander JG, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 324:1991;1852-1857.
49. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology. 19:1994;1407-1413.
50. Harrison PM, Wendon JA, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 23:1996;1067-1072.
51. Mesa ML, Carrizosa R, Marinez-Honduvilla C, Benito M, Fabregat I. Changes in rat liver gene expression induced by thioacetamide: protective role of S-adenosyl-L-methionine by a glutathione-dependent mechanism. Hepatology. 23:1996;600-606.
52. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocytes protein synthesisin vitro. J Exp Med. 169:1989;1467-1472.
53. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA. 90:1993;522-526.
54. Szabo C, Wu C, Milchel JA, Gross SS, Thiemermann C, Vane JR. Platelet activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res. 73:1993;991-998.
55. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 192:1990;245-261.
56. Ikeda I, Kasajima T, Nishikawa T, Yamauchi K, Mitsunaga A. Possible role of enhanced synthesis of nitric oxide in fulminant hepatitis. [abstract] Gastroenterology. 112:1997;A1287.
57. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa J, Curran RD, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radicalmediated hepatic injury. J Leukoc Biol. 52:1992;390-394.
58. Vos TA, Gouw ASH, Klok PA, Havinga R, Van Goor H, Huitema S, et al. Differential effects of nitric oxide inhibitors on endotoxin-induced liver damage in rats. Gastroenterology. 113:1997;1323-1333.
59. Nagase S, Isobe H, Ayukawa K, Sakai H, Hawata H. Inhibition of nitric oxide production increases dimethylnitrosamine-induced liver injury in rats. J Hepatol. 23:1995;601-604.
60. Lee FY, Colombato LA, Albillos A, Groszmann RJ. N omeganitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma expansion and sodium retention in portal hypertensive rats. Hepatology. 17:1993;84-90.
61. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA. 91:1994;6702-6706.
62. McCall TB, Boughton-Smith NK, Palmer RNJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J. 261:1989;293-296.
63. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys. 289:1991;130-136.
64. Bruckdorfer KR, Dee G, Jacobs M, Rice-Evans CA. The protective action of nitric oxide against membrane damage induced by myoglobin radicals. Biochem Soc Trans. 18:1990;285-286.
65. Schlafer M, Kane PF, Kirsch M. Effects of dimethyl sulfoxide on the globally ischemic heart: possible general relevance to hypothermic organ preservation. Cryobiology. 19:1982;61-69.
66. Schiffer CA, Whitaker CI, Schmukler M, Aisner J, Hibert SL. The effect of dimethyl sulfoxide onin vitro platelet function. Thromb Hemostasis. 36:1976;221-229.
67. LeHann TR, Horita A. Effects of dimethyl sulfoxide (DMSO) on prostaglandin synthetase. Proc West Pharmacol Soc. 18:1975;81-82.
68. Sandborn EB, Stephens H, Bendayan M. The influence of dimethyl sulfoxide on cellular ultrastructure an cytochemistry. Ann NY Acad Sci. 243:1975;122-138.
69. Conover TE. Influence of nonionic organic solutes on various reactions of energy conservation and utilization. Ann NY Acad Sci. 243:1975;24-37.
70. Ruigrok TJC, DeMoes D, Slade AM, Nayler WG. The effect of dimethyl sulfoxide on the calcium paradox. Am J Pathol. 103:1981;390-403.
71. Massion PP, Linden A, Inoue M, Mathy M, Grattan KM, Nadel. Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am J Physiol. 271:1996;L838-L843.
72. Wasil M, Halliwell B, Grootveld M, Moorhouse CP, Hutchison DSC, Baum H. The specificity of thiourea, dimethylthiourea and dimethyl sulfoxide as scavengers of hydroxyl radicals. Their protection ofα1-antiproteinase against inactivation by hypochlorous acid. Biochemical J. 243:1987;867-870.
73. Whiteman M, Halliwell B. Thiourea and dimethylthiourea inhibit peroxynitrite-dependent damage: nonspecificity as hydroxyl radical scavengers. Free Rad Biol Med. 22:1997;1309-1312.
74. Ueda T, Toyoshima Y, Kushihashi T, Hishida T, Yashuhara H. Effect of dimethyl sulfoxide pretreatment on activities of lipid peroxide and glutathione peroxidase in the mouse liver after whole-body irradiation. J Toxicol Sci. 18:1993;239-244.
75. Repine JE, Eaton JW, Anders MW, Hoidal JR, Fox RB. Generation of hydroxyl radicals by enzymes, chemicals, and human phagocytesin vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest. 64:1979;1642-1651.
76. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock. 7:1997;90-96.